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Production of the Soluble Form of KIT, s-KIT,
Abolishes Stem Cell Factor-Induced Melanogenesis in
Human Melanocytes
Shinya Kasamatsu1, Akira Hachiya1,2, Kazuhiko Higuchi1, Atsushi Ohuchi1, Takashi Kitahara1 and
Raymond E. Boissy3,4
The signaling of stem cell factor (SCF) and its receptor KIT (membrane-bound KIT; m-KIT) plays an important
role in melanocyte development, survival, proliferation, and melanogenesis. It has been demonstrated in other
systems that a soluble form of m-KIT released from the cell surface (s-KIT) regulates SCF signaling, although
there have been no reports pertaining to the existence and the biological role of s-KIT in melanocytes. In this
study, we therefore examined the involvement of s-KIT in melanogenesis. Western blotting analysis revealed
that treatment with phorbol 12-myristate-13-acetate (PMA) or 4-aminophenylmercuric acetate (APMA) induced
s-KIT production in cultured human melanocytes. Inhibitors of tumor necrosis factor-a-converting enzyme
(TACE) and metalloproteinases (MMPs) muted this release of s-KIT into the media. Human recombinant s-KIT
added to melanocytes inhibited SCF-induced phosphorylation of m-KIT, resulting in suppression of SCF-
induced melanogenesis. Additionally, APMA-induced s-KIT production abolished SCF-induced melanogenesis
as effectively as a KIT-neutralizing antibody. Concomitantly, APMA and TACE inhibitors significantly decreased
and increased melanin synthesis, respectively, in an in vitro skin model. Taken together, these findings provided
an insight into the elaborate mechanism of SCF/m-KIT signaling in human melanocytes and suggested that
production of s-KIT contributes to the regulation of human skin pigmentation.
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INTRODUCTION
The receptor tyrosine kinase membrane-bound KIT protein
(m-KIT) and its ligand stem cell factor (SCF), also referred to
as steel factor, kit ligand or mast cell growth factor, are
encoded by the dominant white spotting (W) locus and the
steel (Sl) locus, respectively. Mutations in either of those loci
elicit similar phenotypes characterized by the loss of neural
crest-derived pigment cells, hematopoietic cells, and primor-
dial germ cells (Matsui et al., 1990; Orr-Urtreger et al., 1990;
Bernstein et al., 1991; Williams et al., 1992; Besmer et al.,
1993; Halaban and Moellmann, 1993; Galli et al., 1994),
suggesting that SCF/m-KIT signaling is essential for survival of
these specific cell types. The involvement of SCF/m-KIT
signaling in melanocyte development during embryogenesis
has been demonstrated using phenotype analysis of Sl and W
mice. In addition, experiments using a monoclonal KIT
antibody (ACK2), an antagonistic blocker of m-KIT function,
also revealed an important role of SCF/m-KIT signaling in the
development of murine melanocytes (Nishikawa et al., 1991;
Okura et al., 1995; Yoshida et al., 1996).
Mutations in the human genes encoding KIT results in
piebaldism, a congenic disorder that is characterized by
amelanotic patches on acral and/or ventral skin surfaces, but
apparently lacking detectable defects in germ cells or in the
hematologic system (Giebel and Spritz, 1991; Spritz et al.,
1992; Ezoe et al., 1995). In addition, intradermal injection of
SCF enhances the number, size, and dendricity of melano-
cytes in normal human skin xenografts, whereas interruption
of SCF binding to its receptor m-KIT by the injection of KIT-
neutralizing antibody decreases these parameters (Grichnik
et al., 1998). Furthermore, SCF/m-KIT signaling also mediates
UVB-induced pigmentation and several pigmentation dis-
orders. We previously reported that UVB irradiation aug-
ments gene and protein expression of membrane-bound SCF
in epidermal keratinocyte to activate neighboring melanocyte
via m-KIT receptors, and injection of KIT-inhibitory antibody
abolishes UVB-induced pigmentation on dorsal skin of
pigmented guinea pig (Hachiya et al., 2001). In the human
epidermis of lentigo seniles, SCF expression is increased
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compared with adjacent normal skin (Hattori et al., 2004). In
dermatofibroma with epidermal hyperpigmentation, SCF
secreted by dermal fibroblasts stimulates melanocytes located
in the epidermis overlying the dermal fibroblast tumor
(Shishido et al., 2001). These lines of evidence clearly
demonstrate the role of SCF/m-KIT signaling in regulating
epidermal melanogenesis under homeostatic, stimulatory,
or pathogenic conditions (including UVB exposure and
pigmentation disorders).
SCF is expressed as both an 18-kDa soluble and a 31-kDa
membrane-bound form, whereas m-KIT is expressed as a
145-kDa glycosylated transmembrane protein and consists of
an extracellular, a transmembrane, and a tyrosine kinase
domain (Broudy, 1997; Zhang et al., 2000; Ronnstrand,
2004; Lennartsson et al., 2005). Moreover, the extracellular
domain of m-KIT was found to consist of five Ig-like domains,
with the first three Ig-like domains and the fourth domain
involved in binding SCF and receptor dimerization, respec-
tively (Blechman et al., 1993, 1995; Lev et al., 1993; Zhang
et al., 2000). Binding and dimerization subsequently cause
autophosphorylation at tyrosine residues of m-KIT, followed
by the activation of downstream signaling cascades
(Blume-Jensen et al., 1991; Ronnstrand, 2004; Lennartsson
et al., 2005). In mast cells, hematopoietic cells, and
endothelial cells, release of the fifth Ig-like extracellular
domain of m-KIT (called soluble form of KIT (s-KIT)),
corresponding to 98–100-kDa glycoprotein, is induced by
stimulants such as phorbol 12-myristate-13-acetate (PMA)
(Yee et al., 1993; Broudy et al., 1994, 2001; Turner et al.,
1995). One of the mechanisms underlying the cleavage
of s-KIT from m-KIT by PMA is considered to be via activation
of protein kinase C (Yee et al., 1993, 1994). Recently, tumor
necrosis factor-a-converting enzyme (TACE) and some matrix
metalloproteinases (MMPs) were also found to catalyze
the production of s-KIT in mast cells (Cruz et al., 2004).
Metalloproteinases activated by divalent metal ions are
classified into two groups, one consisting of membrane-
bound type metalloproteinases, called a disintegrin and
metalloproteinase domain family, and the other consisting
of MMPs (Arribas and Borroto, 2002). TACE belongs to the
disintegrin and metalloproteinase domain family and has
approximately 20 substrates such as tumor necrosis factor-a,
transforming growth factor-b, Notch, as well as m-KIT (Mezyk
et al., 2003; Cruz et al., 2004). TACE is activated by PMA via
activation of protein kinase C, resulting in the production of
s-KIT (Doedens et al., 2003; Cruz et al., 2004). In addition,
the mercurial compound 4-aminophenylmercuric acetate
(APMA) activates TACE and MMPs (Merlos-Suarez et al.,
2001); however, the precise mechanisms of action have not
been delineated.
s-KIT has been detected in vivo in human serum or plasma
(Wypych et al., 1995). The amount of s-KIT is increased in
serum of patients with mastocytosis and correlates with
disease severity, implicating s-KIT as a potential molecular
marker of the disease (Akin et al., 2000; Kanbe et al., 2001).
Additionally, the amount of s-KIT in serum correlates with
leukemic cell burden, graft-versus-host disease, and delayed
engraftment following bone marrow transplantation (Hashino
et al., 1995, 1997; Kawakita et al., 1995; Tajima et al., 1998).
Of note, s-KIT has an ability to bind SCF and functions as a
decoy receptor to inhibit SCF/m-KIT signaling (Dahlen et al.,
2001). Therefore, these data indicate a potential role of s-KIT
in regulation of SCF/m-KIT signaling in m-KIT-harboring cells,
including melanocyte, even though released s-KIT from
melanocytes has not been reported.
In this study, we demonstrate that s-KIT is expressed by
human melanocytes in vitro and in the human epidermis
in vivo. The production of s-KIT is enhanced by stimulants
such as PMA, TACE, and MMP activators. We further
demonstrate that s-KIT itself or release of s-KIT could inhibit
SCF-induced melanogenesis in human melanocytes.
RESULTS
Detection of KIT in soluble and membrane types in human
epidermis in vivo and in human melanocytes in vitro
On the basis of the information that the production of a
soluble form of KIT protein is identified as the appearance
100-kDa protein, whereas an m-KIT protein is identified as a
145-kDa protein, in mast and hematopoietic cells (Yee et al.,
1993; Turner et al., 1995), we investigated whether or not the
ectodomain of m-KIT of human melanocytes was cleaved
endogenously. Western blotting analysis using an KIT
N-terminus-specific antibody revealed that a significant
amount of s-KIT and m-KIT, at approximately 100 and
145-kDa, respectively, was detected in the protein extracts
from human epidermal sheets, suggesting a continuous
production of s-KIT in human epidermis in vivo (Figure 1a)
Subsequently, given that the cited literature also reported that
PMA induces a cleavage of s-KIT (Yee et al., 1993; Broudy
et al., 2001), this stimulant was used in this study to
investigate the induction of s-KIT from human melanocytes.
Western blotting analyses demonstrated differences in
molecular weight between s-KIT and m-KIT in cultured
supernatant of human melanocytes treated by PMA for
4 hours and non-treated melanocyte lysate, respectively
(Figure 1b). In addition, s-KIT production by PMA was found
to be increased in a time-dependent manner, accompanied
by concomitant decrease in the expression of m-KIT,
suggesting that s-KIT is cleaved from m-KIT in human
melanocytes in vitro (Figure 2).
s-KIT inhibited SCF-induced phosphorylation in human
melanocytes
After observing the production of s-KIT in human melano-
cytes, we investigated whether human recombinant s-KIT
inhibits the binding of SCF to m-KIT receptor on melanocytes.
SCF-binding assay demonstrated that human recombinant
s-KIT inhibited the binding of 125I-labeled SCF to m-KIT on
human melanocytes in a dose-dependent manner (Figure 3a),
suggesting a role of s-KIT as a decoy receptor in human
melanocytes, consistent with a previous report on KIT-
transfected mast cells (Dahlen et al., 2001). To further
explore the inhibitory effect of s-KIT on SCF/m-KIT signaling,
the levels of SCF-induced phosphorylation in m-KIT were
investigated in the presence of various concentrations
of human recombinant s-KIT. Western blotting analysis
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demonstrated that s-KIT inhibited SCF-induced phosphoryla-
tion of m-KIT in a dose-dependent manner (Figure 3b).
Involvements of MMPs and TACE in s-KIT production in human
melanocytes
TACE and some MMPs are involved in the production of s-KIT
in mast cells (Cruz et al., 2004). To assess the role of TACE
and MMPs in s-KIT production from human melanocytes,
cells were treated either with an activator of TACE or MMPs
(that is, APMA), a TACE inhibitor (that is, tumor necrosis
factor-a protease inhibitor; TAPI-1), or inhibitors for MMPs
together with PMA. Western blotting analysis with cell lysate
and cultured supernatants of human melanocytes demon-
strated that APMA accelerated the production of s-KIT in a
dose-dependent manner, whereas expression of m-KIT
decreased reciprocally (Figure 4a). In contrast, TAPI-1 and
MMP inhibitor II were found to inhibit PMA-induced s-KIT
production in the supernatant of cultured human melano-
cytes in a dose-dependent manner, whereas MMP-3 inhibitor
VII had no effect on the production of s-KIT (Figure 4b),
suggesting that TACE and some MMPs (except for MMP-3)
mediate the production of s-KIT from human melanocytes.
Production of s-KIT inhibited SCF-induced melanogenesis in
human melanocytes
To examine whether s-KIT production or addition of human
recombinant s-KIT inhibited SCF-induced melanogenesis in
human melanocytes, human melanocytes were cultured with
human recombinant s-KIT, APMA, or KIT-neutralizing
antibody, together with human recombinant SCF for 10 days.
Melanin content measured at absorbance of melanin at
405 nm revealed that induction of melanin by SCF did not
occur in the presence of APMA, similar to the effect of
KIT-neutralizing antibody (Figure 5), consistent with previous
reports (Nishikawa et al., 1991; Okura et al., 1995; Yoshida
et al., 1996). Similarly, human recombinant s-KIT was found
to significantly inhibit melanin synthesis.
Regulation of melanogenesis in human three-dimensional skin
model
To observe the interactions between keratinocytes and
melanocytes, a human three-dimensional (3D) skin model
composed of human epidermal melanocytes and keratino-
cytes was used in this study. Models were treated either with
APMA (an activator of s-KIT cleavage) or TAPI-1 (an inhibitor
of s-KIT cleavage), or left untreated (control), and cultured
for 14 days. Photos of the 3D skin model and melanin content
demonstrated that melanogenesis was significantly sup-
pressed by the addition of APMA, whereas TAPI-1 was found
to significantly stimulate melanin synthesis (Figure 6a and b).
Preferential and coordinated role of s-KIT production in the
regulation of SCF/m-KIT signaling
Changes in the production of s-KIT from human melanocytes
was analyzed after UVB irradiation to investigate the role of
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Figure 1. Production of s-KIT is detected in the human epidermis and in
human melanocytes. (a) Epidermal sheets from three healthy neonatal
foreskins were solubilized in lysis buffer. Samples were analyzed by western
blotting using m-KIT N-terminus- or b-actin-specific antibodies as detailed in
Materials and Methods. The number above the figure indicates sample
number. (b) Supernatant and cell lysate of cultured human melanocytes
treated with or without 100 ngml1 of PMA for 4 hours was concentrated and
analyzed by western blotting using m-KIT N-terminus-specific antibody.
PMA(+) PMA(–)
0 10 60 240 240
m-KIT
*** ***
Time after treatment
(minutes)
Cell lysate
In
te
ns
ity
In
te
ns
ity
1.8
1.6
1.4
1.2
1
0
0.8
0.6
0.4
0.2
1.8
1.6
1.4
1.2
1
2
0
0.8
0.6
0.4
0.2
Supernatant
**
****
***
s-KIT
β-Actin
Figure 2. Time-course analysis of s-KIT production by the addition of PMA in
human melanocytes. Normal human melanocytes were treated with
100 ngml1 PMA for various incubation times. Cultured supernatant was
concentrated and analyzed by western blotting using m-KIT N-terminus-
specific antibody as detailed in Materials and Methods. In addition, cells were
solubilized and analyzed by western blotting using m-KIT C-terminus- or
b-actin-specific antibodies. Each band shows a representative result of
western blotting analyses; the experiment was repeated three times with
similar results. The obtained bands were analyzed with densitometer and
graphs represent relative density. The values reported are means±SD.
**Po0.01; ***Po0.001.
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s-KIT in UVB-induced pigmentation, since expression of
membrane-bound SCF and m-KIT has been reported to
increase in epidermal keratinocyte and melanocyte, respec-
tively, after UVB irradiation (Hachiya et al., 2001, 2004).
Western blotting analyses of cultured supernatant 24 hours
after various doses of UVB exposure demonstrated that
production of s-KIT decreased in a dose-dependent manner,
whereas m-KIT expression increased slightly (Figure 7),
consistent with a previous report (Hachiya et al., 2001).
Furthermore, treatment of human melanocytes with
human recombinant SCF for 4 hours resulted in decrease
of s-KIT production (Figure 8), parallel with the decrease in
m-KIT expression due to its rapid internalization and
degradation after SCF binding (Blume-Jensen et al., 1991).
These findings suggest a preferential and coordinated role of
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Figure 3. Analyses of decoying activity of human recombinant s-KIT for
human recombinant SCF. (a) Normal human melanocytes were treated with
1 nM of 125I-labeled SCF together with various concentrations of s-KIT for
90minutes. Cells were solubilized and the amount of 125I-labeled SCF
binding to KIT receptor on melanocytes was measured by g-counter as
detailed in Materials and Methods. The nonspecific binding value (2,026) was
subtracted from each value shown here. (b) Normal human melanocytes were
incubated with 5 nM of human recombinant SCF together with various
concentrations of human recombinant s-KIT for 10minutes. Cells were
solubilized and analyzed by western blotting using phospho-m-KIT-, m-KIT
C-terminus-, or b-actin-specific antibodies as detailed in Materials and
Methods. Each band shows a representative result of western blotting
analyses, which were repeated three times with similar results. The obtained
bands were analyzed using a densitometer. The values in the graph indicate
the relative ratio of phospho-m-KIT/m-KIT. The values reported are
means±SD. *Po0.05; ***Po0.001.
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Figure 4. Activator or inhibitor of TACE and MMPs regulate the production
of s-KIT in human melanocytes. (a) Normal human melanocytes were treated
with 75 or 150 nM of APMA for 4 hours. Cultured supernatant was
concentrated and analyzed by western blotting using m-KIT N-terminus-
specific antibody as detailed in Materials and Methods. In addition, cells were
solubilized and analyzed by western blotting using m-KIT C-terminus- or
b-actin-specific antibodies. Each band shows a representative result of
western blotting analyses, which were repeated three times with similar
results. The obtained bands were analyzed using a densitometer and the
graph in the figure represents relative density. The values reported are
means±SD; *Po0.05. (b) Normal human melanocytes were pretreated with
various concentrations of MMP inhibitor II, MMP-3 inhibitor VII, or TAPI-1 for
30minutes before the incubation together with 100 ngml1 of PMA for
4 hours. Cultured supernatant of the cells was concentrated and analyzed by
western blotting using m-KIT N-terminus-specific antibody as detailed in
Materials and Methods. Each band shows a representative result of western
blotting analyses, which were repeated three times with similar results. The
obtained bands were analyzed using a densitometer and the values in the
graph represent relative intensity. The values reported are means±SD.
**Po0.01; ***Po0.001.
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s-KIT production in the regulation of SCF/m-KIT signaling
after UVB exposure.
DISCUSSION
Complex coloration of the human epidermis is regulated
in part by the embryonic establishment of melanocytes in
the basal epithelial layer (Rosdahl and Szabo, 1978), the
synthesis of melanin within the melanosome by enzymes and
regulatory proteins (Imokawa and Mishima, 1982; Mishima
and Imokawa, 1983), and the transfer of melanosomes from
melanocytes to keratinocytes (Okazaki et al., 1976). The first
two processes require a complex network of autocrine and
paracrine cytokines produced in the epidermis (Halaban
et al., 1988; Yada et al., 1991; Imokawa et al., 1992, 1995,
1996, 1997, 2000; Yohn et al., 1993; Schauer et al., 1994;
Abdel-Malek et al., 1995; Chakraborty et al., 1996; Sirsjo
et al., 1996; Wintzen and Gilchrest, 1996; Rome´ro-Gaillet
et al., 1997; Funasaka et al., 1998; Hedley et al., 1998; Tada
et al., 1998; Hachiya et al., 2001). These cytokines include in
part basic fibroblast growth factor (FGF) (Halaban et al.,
1988), endothelin-1 (Yada et al., 1991; Imokawa et al., 1992,
1996, 1997, 1995; Yohn et al., 1993; Tada et al., 1998),
a-melanocyte-stimulating hormone (Schauer et al., 1994;
Abdel-Malek et al., 1995; Chakraborty et al., 1996; Wintzen
and Gilchrest, 1996; Funasaka et al., 1998; Hedley et al.,
1998), SCF (Imokawa et al., 1996; Hachiya et al., 2001), and
nitric oxide (Rome´ro-Gaillet et al., 1997). Therefore, the
signaling cascades induced by cytokines are ultimately
necessary to maintain cutaneous pigmentation. SCF/m-KIT
signaling is regulated by increase in the expression in SCF
and m-KIT in keratinocytes and melanocytes, respectively,
and in phosphorylation in m-KIT after UVB irradiation,
resulting in increased epidermal melanogenesis (Hachiya
et al., 2001, 2004). In mast cells, hematopoietic cells, and
endothelial cells, a cleaved, soluble product of KIT, s-KIT,
exists (Yee et al., 1993; Broudy et al., 1994; Turner et al.,
1995) that functions as a decoy receptor to regulate SCF/
m-KIT signaling (Dahlen et al., 2001). In this study, we
provide evidence for the role of s-KIT in melanogenesis,
which to our knowledge has not been reported previously.
We demonstrate that s-KIT was detected both in the cultured
supernatant of human melanocytes and the intact epidermis,
and its production from m-KIT was promoted by stimulants
such as PMA and APMA, an activator of TACE, and MMPs.
Furthermore, s-KIT inhibited SCF-induced phosphorylation of
m-KIT in human melanocytes in a dose-dependent manner,
and production of s-KIT by APMA abolished SCF-induced
melanogenesis.
One of the most important issues addressed in this study is
how s-KIT production from m-KIT abolishes SCF-induced
melanogenesis in human melanocytes. It has been proposed
that s-KIT binds SCF and functions as a decoy receptor to
inhibit SCF/mKIT signaling (Dahlen et al., 2001). Our data
indicate that binding of 125I-labeled-SCF to m-KIT in human
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Figure 5. Production of s-KIT abolishes SCF-induced melanogenesis in
human melanocytes. Normal human melanocytes were incubated with
100 nM of s-KIT, 100 nM of APMA, or 1 mgml1 of m-KIT-neutralizing
antibody, together with 10 nM of human recombinant SCF for 10 days. Cells
were solubilized in 2M NaOH. Melanin contents were measured by an
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Figure 6. Induction and inhibition of s-KIT production decreases and
increases melanogenesis in 3D human skin models, respectively.
(a) Photographs. (b) Melanin content. 3D human skin models were cultured
for 14 days in the presence of 1 mM of APMA or 1 mM of TAPI-1. Cells were
solubilized in 2 M NaOH followed by measurement of melanin content
using an absorbance meter. The values reported are means±SD. *Po0.05;
***Po0.001.
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melanocytes was suppressed by the addition of human
recombinant s-KIT in a dose-dependent manner, and
was accompanied by dose-dependent interruption of SCF-
induced phosphorylation in m-KIT. These results indicate that
s-KIT is a potent decoy for SCF, resulting in the inhibition of
SCF/m-KIT signaling in human melanocytes. However,
human recombinant s-KIT was shown to only partially inhibit
SCF-induced melanogenesis, whereas addition of APMA was
found to abolish SCF-induced melanogenesis as effectively as
KIT-neutralizing antibody, presumably due to the fact that
APMA cleaves s-KIT from m-KIT, resulting in both increase in
decoying s-KIT and depletion of m-KIT. The partial role of
human recombinant s-KIT as a decoy for SCF may be due to
lack of its glycosylation, present in the native s-KIT. Western
blotting analysis revealed that human recombinant s-KIT
exists as a 60-kDa protein (data not shown), whereas the fully
glycosylated endogenous s-KIT exists as a 100-kDa protein in
the cultured supernatant of human melanocytes and intact
epidermis, consistent with a previous report indicating that
endogenous s-KIT is an approximately 100-kDa polypeptide
glycosylated predominantly with N-linked carbohydrate and
a small amount of O-linked carbohydrate (Wypych et al.,
1995). Of significance, glycosylated s-KIT expressed in baby
hamster kidney cells abolishes SCF-induced cell proliferation
in the murine mast cell line IC2 (Dahlen et al., 2001),
suggesting the requirement for glycosylation of s-KIT for
efficient decoy function. The role of endogenous glycosylated
s-KIT as a decoy in abolishing SCF-induced melanogenesis
in vivo remains to be clarified. We identified a significant
constitutive amount of s-KIT in the human epidermis, without
any stimuli (Figure 1a). In addition, we demonstrated an
increase in melanogenesis by the addition of TAPI-1, an
inhibitor of TACE and MMPs, to the 3D skin model (Figure 6).
These results support the role of glycosylated s-KIT in
endogenously regulating cutaneous pigmentation.
Expression of s-KIT from the membrane of human
melanocytes may also be exogenously regulated. Previous
reports demonstrated that UVB irradiation stimulates cuta-
neous pigmentation by inducing the expression of a variety of
cytokines and their receptors, including SCF and m-KIT, in
keratinocytes and melanocytes, respectively (Hachiya et al.,
2001, 2004). We demonstrated that m-KIT expression was
slightly increased after UVB exposure in a dose-dependent
manner in human melanocytes, consistent with a previous
report (Hachiya et al., 2001). Correlatively, the expression of
s-KIT was decreased in a dose-dependent manner in the
cultured supernatant of human melanocytes after UVB
exposure. Similarly, addition of SCF to human melanocytes
induced a decrease in the expression of m-KIT, consistent with
a previous report demonstrating that m-KIT is phosphorylated
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Figure 7. UVB irradiation increases and decreases m-KIT expression and
s-KIT production, respectively. Normal human melanocytes were exposed to
UVB irradiation with the indicated doses, followed by cultivation for
24 hours. Cultured supernatant was concentrated and analyzed by western
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repeated three times with similar results. The obtained bands were analyzed
using a densitometer and the values in the graphs represent relative
intensities. The values reported are means±SD; *Po0.05.
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Figure 8. Addition of human recombinant SCF decreases the expression of
m-KIT and production of s-KIT in human melanocytes. Normal human
melanocytes were treated with 100 ngml- of PMA or 10 nM of human
recombinant SCF for 4 hours. Cultured supernatant was concentrated and
analyzed by western blotting using m-KIT N-terminus-specific antibody as
detailed in Materials and Methods. In addition, cells were solubilized and
analyzed by western blotting using m-KIT C-terminus- or b-actin-specific
antibodies. Each band shows a representative result of western blotting
analyses, which were repeated three times with similar results. The obtained
bands were analyzed using a densitometer and the values in the graphs
represent relative intensities. The values reported are means±SD. *Po0.05;
**Po0.01.
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and internalized rapidly after the binding of SCF to m-KIT,
followed by ubiquitinization and degradation of m-KIT by
proteasome (Ronnstrand, 2004). We also demonstrated an SCF
induced a decrease in s-KIT in the cultured supernatant of
human melanocytes, consistent with a previous report show-
ing that addition of SCF to mast cells decreases the expression
of both m-KIT and s-KIT (Cruz et al., 2004). On the other hand,
it has been documented that the SCF produced by epidermal
keratinocytes necessary for the maintenance of epidermal
melanocytes is predominantly the membrane bound type
(Longley et al., 1993; Hamann et al., 1995; Kunisada et al.,
1998), and that binding of membrane-bound SCF to m-KIT
results in slower internalization of m-KIT (Kapur et al., 1998).
These findings indicated the preferential and coordinated
role of s-KIT production in the regulation of SCF/m-KIT
signaling during UVB-induced melanogenesis, by decreasing
its cleavage in order to maintain SCF/m-KIT signaling.
TACE is ubiquitously expressed in human tissues, includ-
ing human epidermis (Black et al., 1997; Kawaguchi et al.,
2004). In this study, we demonstrated that TACE and some
forms of MMPs are involved in the production of s-KIT in
human melanocytes. There were the following three key
findings: (1) exogenous addition of PMA and APMA caused
human melanocytes to produce s-KIT in a dose-dependent
manner, (2) exogenous addition of a TACE inhibitor TAPI-1
and MMP inhibitor II decreased PMA-induced s-KIT produc-
tion in human melanocytes in a dose-dependent manner, and
(3) exogenous addition of TAPI-1 increased melanogenesis in
3D human skin model. However, the involvement of the
changes in SCF/m-KIT signaling remains to be clarified in 3D
human skin model after the addition of APMA and TAPI-1 to
ensure the role of s-KIT production in human melanogenesis,
because TACE has been reported to cleave various membrane
proteins such as transforming growth factor-b and Notch,
which also affect melanogenesis (Kim et al., 2004; Moriyama
et al., 2006; Schouwey et al., 2007; Stavroulaki et al., 2008).
Also unexplored are the specific forms of MMPs that function
to produce s-KIT and the role of keratinocytes in producing
s-KIT from melanocytes in a paracrine manner. Preliminary
reverse transcriptase–PCR analysis data indicated that mRNA
transcript expression of TACE was higher in human keratino-
cytes than in human melanocytes (data not shown).
In conclusion, our data demonstrated that production of
s-KIT was detected and increased by the addition of TACE
and MMPs activators in both the cultured supernatant of
human melanocytes in vitro and intact epidermis in a dose-
dependent manner, and that s-KIT production abolished SCF/
m-KIT signaling, resulting in complete inhibition of SCF-
induced melanogenesis. To our knowledge, this information
is previously unreported. These findings provide a new
insight into an elaborate mechanism of SCF/m-KIT signaling
in human melanocytes and suggest that production of s-KIT is
involved in the regulation of human skin pigmentation.
MATERIALS AND METHODS
Materials
Normal human epidermal melanocytes and 3D human skin models
(MEL-300A) were purchased from Kurabo Corporation (Osaka,
Japan). Institutional approval was not required for experiments.
Anti-m-KIT N-terminus-specific antibody was obtained from Santa
Cruz Biotechnology Inc. (Santa Cruz, CA). Anti-m-KIT C-terminus-
specific antibody and recombinant SCF were provided from
Immuno-Biological Laboratories Co. (Gunma, Japan). Anti-
phospho-m-KIT-specific antibody was purchased from Cell Signaling
Technology Inc. (Danvers, MA). Anti-b-actin-specific antibody was
obtained from Sigma-Aldrich Co. (St Louis, MO). Recombinant
human s-KIT of over 95% purity was purchased from R&D Systems
Inc. (Minneapolis, MN). A DNA sequence encoding the extracellular
domain of human KIT (amino-acid residues 1–520) was expressed
in Sf21 cells. Non-glycosylated recombinant s-KIT migrated as a
60-kDa protein in SDS–PAGE. Other chemicals were of reagent
grade.
Cell culture
Normal human epidermal melanocytes were maintained in Medium
254 (Kurabo Corporation) supplemented with 5mgml1 of insulin,
5mgml1 of transferrin, 3 ngml1 of human recombinant FGF,
0.18mgml1 of hydrocortisone, 3 mgml1 of heparin, 10 ngml1 of
PMA, 0.2% (v/v) of bovine putative extract, and 0.5% (v/v) of fetal
bovine serum at 37 1C with 5% CO2, as described previously (Yada
et al., 1991).
Western blotting
To investigate the protein expression levels of m-KIT and/or s-KIT
cleavage product in human cultured melanocytes and cultured
supernatant, respectively, subconfluent melanocytes in a dish of
10 cm diameter were cultured in the conditioned medium (Medium
254 supplemented with 5 mgml1 of insulin, 5mgml1 of transferrin,
3 ngml1 of human recombinant FGF, 0.18mgml1 of hydrocorti-
sone, 3mgml1 of heparin, 0.2% (v/v) of bovine putative extract, and
0.5% (v/v) of fetal bovine serum) for 3 days before the addition of
stimuli. Then used media were replaced by fresh conditioned
medium (Medium 254 supplemented with 5mgml1 of insulin,
3 ngml1 of human recombinant FGF, and 3 mgml1 of heparin) and
100ngml1 of PMA, 10 nM of human recombinant SCF, APMA
(75–150 nM) (EMD Biosciences Inc., San Diego, CA) , MMP inhibitor
II (2–20 mM) (EMD Biosciences Inc.), MMP III inhibitor VII (2–20 mM)
(EMD Biosciences Inc.), or TAPI-1 (2–20mM) (EMD Biosciences, Inc.)
was added to the culture. In another experiment, human melano-
cytes were exposed to UVB irradiation by UVB lamps (Toshiba SE
lamps for UVB with a peak of emission near 312 nm). To examine
the expression levels of m-KIT, human melanocyte-derived protein
(5mg) solubilized in cell lysis buffer (Cell Signaling Technology) with
1mM phenylmethylsulfonyl fluoride (Sigma-Aldrich Co.) was sepa-
rated on 7.5% SDS gels (Bio-Rad Laboratories, Hercules, CA). To
detect the s-KIT cleaved from melanocyte surface, each cultured
supernatant was filtered with a 0.45-mm membrane (Millipore Co.,
Billerica, MA) and quantified. The filtered supernatant was
concentrated over 40-fold using centricon plus 20. The reduced
supernatant was then quantified. On the basis of this quantification,
supernatants were then subsequently diluted with distilled water in
order to attain a final concentration of 40-fold, thus normalizing all
samples. Twelve microliters of concentrated supernatant were
separated on 7.5% SDS gel. They were then transferred to Sequi-
Blot PVDF membrane (Bio-Rad Laboratories) and incubated with
a purified polyclonal rabbit antibody specific for the C-terminus of
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m-KIT (0.1 mgml1) or for the N-terminus of m-KIT (0.2 mgml1),
followed by incubation with secondary antibody corresponding to
rabbit IgG (GE Healthcare UK Ltd, Buckinghamshire, UK). Subse-
quent visualization of antibody recognition was performed using
Enhanced ChemiLuminescence Plus (GE Healthcare UK Ltd)
according to the manufacturer’s instructions.
Subconfluent melanocytes in six-well-plates were cultured in the
conditioned medium (Medium 254 supplemented with 5 mgml1 of
insulin, 5mgml1 of transferrin, 3 ngml1 of human recombinant
FGF, 0.18mgml1 of hydrocortisone, 3mgml1 of heparin, 0.2%
(v/v) of bovine putative extract, and 0.5% (v/v) of fetal bovine serum)
for 3 days before addition of stimuli to analyze the phosphorylation
level of m-KIT. The media were then changed to fresh conditioned
medium and 10 nM of human recombinant SCF and/or various
concentrations of s-KIT were added to the media. Following
10minutes of stimuli, the plates were washed twice with ice-cold
phosphate-buffered saline (PBS) and cells were solubilized in cell
lysis buffer with 1mM of phenymethylsulfonyl fluoride. The samples
were separated on 7.5% SDS gels, transferred to Sequi-Blot PVDF
membrane, and incubated with a purified polyclonal rabbit antibody
specific for phospho-m-KIT (1,000-fold dilution). Subsequent visua-
lization was performed as described above.
To examine the protein expression levels of m-KIT and s-KIT
cleavage in human epidermis in vivo, neonatal foreskin was
obtained from routine circumcision (Christ Hospital, Cincinnati,
OH) and incubated at 80 1C for 1 day. Immediately after
incubation in H2O for 2minutes at 60 1C, tissue was kept on ice
for 10minutes in order to separate epidermal sheet from the
underlying dermis. The epidermal samples were then lysed using a
cell lysis buffer supplemented with 1mM of phenylmethylsulfonyl
fluoride and 170 mg of solubilized protein were separated on 7.5%
SDS gels to detect the expression of m-KIT and s-KIT. Subsequent
procedures were performed as described above.
In each experiment above, the amount of protein loaded was
normalized against a control protein, b-actin, with a mAb specific for
b-actin (Sigma-Aldrich Co.).
Radiolabeling and ligand-binding assay
The SCF binding assay was performed as described elsewhere (Lev
et al., 1992). Human recombinant SCF was labeled with 125I (GE
Healthcare UK Ltd) using IODO-GEN iodination reagent (Pierce
Biotechnology Inc. Rockford, IL). For the binding assay, subconfluent
melanocytes in 24-well plates were washed with PBS and were then
incubated with 1 nM of 125I-labeled SCF and a variety of concentra-
tions of s-KIT in 300ml of binding buffer (RPMI 1640 medium
containing 0.05% BSA) for 90minutes at 37 1C. The plates were
rinsed five times with ice-cold PBS and melanocytes were
solubilized in 500 ml of 2M NaOH; radioactivity was counted in a
g-counter (Canberra Packard GmbH, Schwadorf, Austria). Nonspe-
cific binding was determined by parallel binding experiments in the
presence of 100-fold excess of unlabeled SCF.
Measurement of melanin content in human cultured
melanocytes
To measure the amount of melanin content in human melanocytes,
5 104 melanocytes were cultured in the conditioned medium
(Medium 254 supplemented with 5mgml1 of insulin, 5mgml1 of
transferrin, 3 ngml1 of human recombinant FGF, 0.18mgml1 of
hydrocortisone, 3mgml1 of heparin, 0.2% (v/v) of bovine putative
extract, and 0.5% (v/v) of fetal bovine serum) in six-well-plates and
100nM of human recombinant s-KIT, 100 nM of APMA, or 1 mgml1
of KIT-neutralizing antibody (K44.2; Lab Vision Co., Fremont, CA)
was added to the culture together with 10 nM of human recombinant
SCF. After culturing for 10 days, the wells were washed three times
with PBS and cells were solubilized in 200ml of 2M NaOH. Melanin
content in human cultured melanocytes was measured by an
absorbance meter (Microplate Reader Model 550; Bio-Rad Labora-
tories) using a 405-nm filter.
Measurement of melanin content in 3D human skin models
According to the manufacturer’s instructions, 3D human skin models
were maintained in EPI-100LLMM medium (Kurabo Corporation) at
37 1C with 5% CO2. Skin models were incubated with 1 mM APMA or
1mM TAPI-1 for 14 days. Photographs of skin models were taken
when cells were harvested. Cells were washed three times with PBS,
5% (v/v) of trichloroacetic acid, and diethyl ether mixed with three
times volume of ethanol in turn. Then, cells were washed once with
diethyl ether and incubated at 50 1C for 2 hours until dry. Cells were
solubilized in 200ml of 2M NaOH. Melanin content in 3D human
skin model was measured by an absorbance meter using a 405-nm
filter, as described above.
Statistics
The level of significance of the difference was calculated by the
Student’s t-test. The differences in the mean or raw values among
treatment groups were considered significant when Po0.05.
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